Daxor Corporation (DXR)
NASDAQ: DXR · IEX Real-Time Price · USD
9.88
+0.22 (2.28%)
May 2, 2024, 4:00 PM EDT - Market closed
Daxor Revenue
In the year 2023, Daxor had annual revenue of $34.59M with 448.16% growth. Revenue in the quarter ending December 31, 2023 was $36.35M, a -11,314.54% decrease year-over-year.
Revenue (ttm)
$34.67M
Revenue Growth
-18,720.02%
P/S Ratio
1.35
Revenue / Employee
$937,080
Employees
37
Market Cap
46.78M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 34.59M | 28.28M | 448.16% |
Dec 31, 2022 | 6.31M | 489.11K | 8.40% |
Dec 31, 2021 | 5.82M | 6.82M | -684.28% |
Dec 31, 2020 | -996.30K | -881.31K | 766.41% |
Dec 31, 2019 | -114.99K | 803.46K | -87.48% |
Dec 31, 2018 | -918.45K | 93.14K | -9.21% |
Dec 31, 2017 | -1.01M | -2.85M | -155.12% |
Dec 31, 2016 | 1.84M | 9.28M | -124.66% |
Dec 31, 2015 | -7.44M | -3.39M | 83.63% |
Dec 31, 2014 | -4.05M | 7.50M | -64.93% |
Dec 31, 2013 | -11.56M | -9.46M | 449.78% |
Dec 31, 2012 | -2.10M | -3.38M | -264.57% |
Dec 31, 2011 | 1.28M | -301.84K | -19.11% |
Dec 31, 2010 | 1.58M | -109.57K | -6.49% |
Dec 31, 2009 | 1.69M | -72.23K | -4.10% |
Dec 31, 2008 | 1.76M | -108.72K | -5.81% |
Dec 31, 2007 | 1.87M | 383.33K | 25.79% |
Dec 31, 2006 | 1.49M | 142.91K | 10.64% |
Dec 31, 2005 | 1.34M | 125.13K | 10.27% |
Dec 31, 2004 | 1.22M | -1.95M | -61.51% |
Dec 31, 2003 | 3.17M | 463.50K | 17.15% |
Dec 31, 2002 | 2.70M | 1.94M | 256.28% |
Dec 31, 2001 | 758.37K | 12.58K | 1.69% |
Dec 31, 2000 | 745.79K | 170.41K | 29.62% |
Dec 31, 1999 | 575.38K | 275.38K | 91.79% |
Dec 31, 1998 | 300.00K | -200.00K | -40.00% |
Dec 31, 1997 | 500.00K | -2.30M | -82.14% |
Dec 31, 1996 | 2.80M | -1.90M | -40.43% |
Dec 31, 1995 | 4.70M | 100.00K | 2.17% |
Dec 31, 1994 | 4.60M | -200.00K | -4.17% |
Dec 31, 1993 | 4.80M | -1.30M | -21.31% |
Dec 31, 1992 | 6.10M | 2.20M | 56.41% |
Dec 31, 1991 | 3.90M | -700.00K | -15.22% |
Dec 31, 1990 | 4.60M | 2.40M | 109.09% |
Dec 31, 1989 | 2.20M | -2.20M | -50.00% |
Dec 31, 1988 | 4.40M | 2.50M | 131.58% |
Dec 31, 1987 | 1.90M | 100.00K | 5.56% |
Dec 31, 1986 | 1.80M | - | - |
Dec 31, 1985 | 1.80M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cutera | 230.18M |
Nortech Systems | 139.33M |
IRIDEX | 51.87M |
Cytosorbents | 36.35M |
Aadi Bioscience | 24.35M |
InspireMD | 6.21M |
Matinas BioPharma Holdings | 1.10M |
DXR News
- 22 days ago - Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital - GlobeNewsWire
- 5 weeks ago - Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics - GlobeNewsWire
- 5 weeks ago - Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 - GlobeNewsWire
- 6 weeks ago - Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - GlobeNewsWire
- 6 weeks ago - Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023 - GlobeNewsWire
- 7 weeks ago - Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base - GlobeNewsWire
- 7 weeks ago - Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients - GlobeNewsWire
- 2 months ago - Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference - GlobeNewsWire